Neil F. McFarlane Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil F. McFarlane.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil F. McFarlane. Neil F. McFarlane is an Chief Executive Officer in Adamas Pharmaceuticals Inc ($ADMS) and a Chief Operating Officer in Retrophin, Inc. ($RTRX).
Address: C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO 92130 CA
Companies in which Neil F. McFarlane is an Insider
Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neil F. McFarlane: Chief Executive Officer
Holdings: 525,000 shares
Current Value: $8,484,000
Latest Transaction: Mar 03 2021
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neil F. McFarlane: Chief Operating Officer
Holdings: 27,972 shares
Current Value: $561,398
Latest Transaction: May 16 2019
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Neil F. McFarlane
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 300,000 | 0 | 525,000 | 225 K to 525 K (+133.33 %) |
| Mar 20 2020 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Option Exercise | A | 1.99 | 200,000 | 398,000 | 200,000 | |
| Mar 20 2020 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 225,000 | 125 K to 225 K (+80.00 %) |
| Sep 17 2019 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Option Exercise | A | 6.25 | 250,000 | 1,562,500 | 250,000 | |
| Sep 17 2019 | ADMS | Adamas Pharmaceuti ... | McFarlane Neil F. | Chief Executive Off ... | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
| May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 18.71 | 984 | 18,411 | 26,988 | 28 K to 27 K (-3.52 %) |
| May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 17.78 | 984 | 17,496 | 27,972 | 29 K to 28 K (-3.40 %) |